Adherent-invasive Escherichia coli, strain LF82 disrupts apical junctional complexes in polarized epithelia

BMC Microbiology

Volumn 9, Issue , 2009, Pages

  Wine, Eytan ^a,c   Ossa, Juan C ^a   Gray Owen, Scott D ^b   Sherman, Philip M ^a  

^a HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; UNCLASSIFIED DRUG; ZONULA OCCLUDENS 1; MEMBRANE PROTEIN; PHOSPHOPROTEIN; ZONULA OCCLUDENS 1 PROTEIN; ZONULA OCCLUDENS-1 PROTEIN;

ANIMAL CELL; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; CELL DISRUPTION; CELL MEMBRANE PERMEABILITY; CELL STRAIN; CELLULAR DISTRIBUTION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOPLASM; ELECTRIC RESISTANCE; ENTERITIS; EPITHELIUM CELL; ESCHERICHIA COLI; HUMAN; HUMAN CELL; INTESTINE CELL; INTESTINE INJURY; MACROMOLECULE; NONHUMAN; PATHOGENESIS; PROTEIN LOCALIZATION; TIGHT JUNCTION; TRANSMISSION ELECTRON MICROSCOPY; ANIMAL; BACTERIUM ADHERENCE; CELL LINE; DOG; ESCHERICHIA COLI INFECTION; METABOLISM; MICROBIOLOGY; PATHOGENICITY; ULTRASTRUCTURE;

ESCHERICHIA COLI;

ANIMALS; BACTERIAL ADHESION; CELL LINE; CELL MEMBRANE PERMEABILITY; DOGS; EPITHELIAL CELLS; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; LYSOSOMAL-ASSOCIATED MEMBRANE PROTEIN 1; MEMBRANE PROTEINS; MICROSCOPY, ELECTRON, TRANSMISSION; PHOSPHOPROTEINS;

EID: 70349150966     PISSN: 14712180     EISSN: 14712180     Source Type: Journal    
DOI: 10.1186/1471-2180-9-180     Document Type: Article

References (45)

1. Unravelling the pathogenesis of inflammatory bowel disease. RJ Xavier DK Podolsky, Nature 2007 448 427 434 10.1038/nature06005 17653185
2. Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum. GR D'Haens K Geboes M Peeters F Baert F Penninckx P Rutgeerts, Gastroenterology 1998 114 262 267 10.1016/S0016-5085(98) 70476-7 9453485
3. Probiotics and inflammatory bowel disease: is there a scientific rationale? F Shanahan, Inflamm Bowel Dis 2000 6 107 115 10833070
4. Biomedicine. Puzzling out the pains in the gut. J Marx, Science 2007 315 33 35 10.1126/science.315.5808.33 17204619
5. Experimental models of inflammatory bowel disease reveal innate, adaptive, and regulatory mechanisms of host dialogue with the microbiota. CO Elson Y Cong VJ McCracken RA Dimmitt RG Lorenz CT Weaver, Immunol Rev 2005 206 260 276 10.1111/j.0105-2896.2005.00291.x 16048554
6. Mechanisms of disease: pathogenesis of Crohn's disease and ulcerative colitis. RB Sartor, Nat Clin Pract Gastroenterol Hepatol 2006 3 390 407 10.1038/ncpgasthep0528 16819502
7. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. DN Frank AL St Amand RA Feldman EC Boedeker N Harpaz NR Pace, Proc Natl Acad Sci USA 2007 104 13780 13785 10.1073/pnas.0706625104 17699621
8. Culture of Mycobacterium avium subspecies paratuberculosis from the blood of patients with Crohn's disease. SA Naser G Ghobrial C Romero JF Valentine, Lancet 2004 364 1039 1044 10.1016/S0140-6736(04)17058-X 15380962
9. Detection of Mycobacterium avium subspecies paratuberculosis from patients with Crohn's disease using nucleic acid-based techniques: a systematic review and meta-analysis. I Abubakar D Myhill SH Aliyu PR Hunter, Inflamm Bowel Dis 2008 14 401 410 10.1002/ibd.20276 17886288
10. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. H Sokol B Pigneur L Watterlot O Lakhdari LG Bermudez-Humaran JJ Gratadoux S Blugeon C Bridonneau JP Furet G Corthier, et al. Proc Natl Acad Sci USA 2008 105 16731 16736 10.1073/pnas.0804812105 18936492
11. Microbial influences in inflammatory bowel diseases. RB Sartor, Gastroenterology 2008 134 577 594 10.1053/j.gastro.2007.11.059 18242222
12. Role of bacteria in the etiopathogenesis of inflammatory bowel disease. N Barnich A Darfeuille-Michaud, World J Gastroenterol 2007 13 5571 5576 17948930 (Pubitemid 350031476)
13. High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease. A Darfeuille-Michaud J Boudeau P Bulois C Neut AL Glasser N Barnich MA Bringer A Swidsinski L Beaugerie JF Colombel, Gastroenterology 2004 127 412 421 10.1053/j.gastro.2004.04.061 15300573
14. Molecular diversity of Escherichia coli in the human gut: New ecological evidence supporting the role of adherent-invasive E. coli (AIEC) in Crohn's disease. M Martinez-Medina X Aldeguer M Lopez-Siles F Gonzalez-Huix C Lopez-Oliu G Dahbi JE Blanco J Blanco LJ Garcia-Gil A Darfeuille-Michaud, Inflamm Bowel Dis 2009 15 872 82 10.1002/ibd.20860 19235912
15. CEACAM6 acts as a receptor for adherent-invasive E. coli, supporting ileal mucosa colonization in Crohn disease. N Barnich FA Carvalho AL Glasser C Darcha P Jantscheff M Allez H Peeters G Bommelaer P Desreumaux JF Colombel, et al. J Clin Invest 2007 117 1566 1574 10.1172/JCI30504 17525800
16. Inflammatory bowel disease and the apical junctional complex. M Bruewer S Samarin A Nusrat, Ann N Y Acad Sci 2006 1072 242 252 10.1196/annals.1326.017 17057204
17. Inflammatory bowel disease: is it really just another break in the wall? CR Weber JR Turner, Gut 2007 56 6 8 10.1136/gut.2006.104182 17172583
18. Intestinal permeability and the prediction of relapse in Crohn's disease. J Wyatt H Vogelsang W Hubl T Waldhoer H Lochs, Lancet 1993 341 1437 1439 10.1016/0140-6736(93)90882-H 8099141
19. Increased intestinal permeability and NOD2 variants in familial and sporadic Crohn's disease. R D'Inca V Annese V di Leo A Latiano V Quaino C Abazia MG Vettorato GC Sturniolo, Aliment Pharmacol Ther 2006 23 1455 1461 10.1111/j.1365-2036.2006.02916.x 16669960
20. Inflammatory processes have differential effects on claudins 2, 3 and 4 in colonic epithelial cells. S Prasad R Mingrino K Kaukinen KL Hayes RM Powell TT MacDonald JE Collins, Lab Invest 2005 85 1139 1162 10.1038/labinvest.3700316 16007110
21. Changes in expression and distribution of claudin 2, 5 and 8 lead to discontinuous tight junctions and barrier dysfunction in active Crohn's disease. S Zeissig N Burgel D Gunzel J Richter J Mankertz U Wahnschaffe AJ Kroesen M Zeitz M Fromm JD Schulzke, Gut 2007 56 61 72 10.1136/gut.2006.094375 16822808
22. Disruption of the epithelial apical-junctional complex by Helicobacter pylori CagA. MR Amieva R Vogelmann A Covacci LS Tompkins WJ Nelson S Falkow, Science 2003 300 1430 1434 10.1126/science.1081919 12775840
23. Lactobacillus rhamnosus strain GG prevents enterohemorrhagic Escherichia coli O157:H7-induced changes in epithelial barrier function. KC Johnson-Henry KA Donato G Shen-Tu M Gordanpour PM Sherman, Infect Immun 2008 76 1340 1348 10.1128/IAI.00778-07 18227169
24. Novel effects of the prototype translocating Escherichia coli, strain C25 on intestinal epithelial structure and barrier function. M Zareie J Riff K Donato DM McKay MH Perdue JD Soderholm M Karmali MB Cohen J Hawkins PM Sherman, Cell Microbiol 2005 7 1782 1797 10.1111/j.1462-5822.2005.00595.x 16309464
25. Bile acids modulate tight junction structure and barrier function of Caco-2 monolayers via EGFR activation. F Raimondi P Santoro MV Barone S Pappacoda ML Barretta M Nanayakkara C Apicella L Capasso R Paludetto, Am J Physiol Gastrointest Liver Physiol 2008 294 906 913 10.1152/ajpgi.00043.2007 18239063
26. Transforming growth factor-beta regulation of epithelial tight junction proteins enhances barrier function and blocks enterohemorrhagic Escherichia coli O157:H7-induced increased permeability. KL Howe C Reardon A Wang A Nazli DM McKay, Am J Pathol 2005 167 1587 1597 16314472
27. Regulation of the intestinal epithelial barrier by the apical junctional complex. MG Laukoetter M Bruewer A Nusrat, Curr Opin Gastroenterol 2006 22 85 89 10.1097/01.mog.0000203864.48255.4f 16462161
28. Helicobacter pylori CagA targets PAR1/MARK kinase to disrupt epithelial cell polarity. I Saadat H Higashi C Obuse M Umeda N Murata-Kamiya Y Saito H Lu N Ohnishi T Azuma A Suzuki, et al. Nature 2007 447 330 333 10.1038/nature05765 17507984
29. Invasive ability of an Escherichia coli strain isolated from the ileal mucosa of a patient with Crohn's disease. J Boudeau AL Glasser E Masseret B Joly A Darfeuille-Michaud, Infect Immun 1999 67 4499 4509 10456892
30. Microbes in gastrointestinal health and disease. AS Neish, Gastroenterology 2009 136 65 80 10.1053/j.gastro.2008.10.080 19026645
31. Targeted epithelial tight junction dysfunction causes immune activation and contributes to development of experimental colitis. L Su L Shen DR Clayburgh SC Nalle EA Sullivan JB Meddings C Abraham JR Turner, Gastroenterology 2009 136 551 563 10.1053/j.gastro.2008.10.081 19027740
32. Adherent-invasive Escherichia coli and Crohn's disease. N Barnich A Darfeuille-Michaud, Curr Opin Gastroenterol 2007 23 16 20 10.1097/MOG. 0b013e3280105a38 17133079 (Pubitemid 44875904)
33. CEACAM1: contact-dependent control of immunity. SD Gray-Owen RS Blumberg, Nat Rev Immunol 2006 6 433 446 10.1038/nri1864 16724098
34. Invasive Escherichia coli are a feature of Crohn's disease. M Sasaki SV Sitaraman BA Babbin P Gerner-Smidt EM Ribot N Garrett JA Alpern A Akyildiz AL Theiss A Nusrat, et al. Lab Invest 2007 87 1042 1054 10.1038/labinvest.3700661 17660846
35. Differential roles for actin polymerization and a myosin II motor in assembly of the epithelial apical junctional complex. AI Ivanov D Hunt M Utech A Nusrat CA Parkos, Mol Biol Cell 2005 16 2636 2650 10.1091/mbc.E05-01-0043 15800060
36. Helicobacter pylori CagA induces a transition from polarized to invasive phenotypes in MDCK cells. F Bagnoli L Buti L Tompkins A Covacci MR Amieva, Proc Natl Acad Sci USA 2005 102 16339 16344 10.1073/pnas.0502598102 16258069
37. Escherichia coli isolated from a Crohn's disease patient adheres, invades, and induces inflammatory responses in polarized intestinal epithelial cells. T Eaves-Pyles CA Allen J Taormina A Swidsinski CB Tutt GE Jezek M Islas-Islas AG Torres, Int J Med Microbiol 2008 298 397 409 10.1016/j.ijmm.2007. 05.011 17900983
38. Enteropathogenic Escherichia coli, Shigella flexneri, and Listeria monocytogenes recruit a junctional protein, zonula occludens-1, to actin tails and pedestals. M Hanajima-Ozawa T Matsuzawa A Fukui S Kamitani H Ohnishi A Abe Y Horiguchi M Miyake, Infect Immun 2007 75 565 573 10.1128/IAI.01479-06 17118974
39. Campylobacter jejuni mediated disruption of polarized epithelial monolayers is cell-type specific, time dependent, and correlates with bacterial invasion. E Wine VL Chan PM Sherman, Pediatr Res 2008 64 599 604 10.1203/PDR.0b013e31818702b9 18679160
40. Fibronectin-facilitated invasion of T84 eukaryotic cells by Campylobacter jejuni occurs preferentially at the basolateral cell surface. MR Monteville ME Konkel, Infect Immun 2002 70 6665 6671 10.1128/IAI.70.12.6665-6671.2002 12438340
41. The Crohn's disease-associated adherent-invasive Escherichia coli strain LF82 replicates in mature phagolysosomes within J774 macrophages. MA Bringer AL Glasser CH Tung S Meresse A Darfeuille-Michaud, Cell Microbiol 2006 8 471 484 10.1111/j.1462-5822.2005.00639.x 16469058
42. NOD2-deficient mice have impaired resistance to Mycobacterium tuberculosis infection through defective innate and adaptive immunity. M Divangahi S Mostowy F Coulombe R Kozak L Guillot F Veyrier KS Kobayashi RA Flavell P Gros MA Behr, J Immunol 2008 181 7157 7165 18981137
43. A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1. J Hampe A Franke P Rosenstiel A Till M Teuber K Huse M Albrecht G Mayr FM De La Vega J Briggs, et al. Nat Genet 2007 39 207 211 10.1038/ng1954 17200669 (Pubitemid 46184351)
44. Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1beta production. T Saitoh N Fujita MH Jang S Uematsu BG Yang T Satoh H Omori T Noda N Yamamoto M Komatsu, et al. Nature 2008 456 264 268 10.1038/nature07383 18849965
45. CARD15 variants determine a disturbed early response of monocytes to adherent-invasive Escherichia coli strain LF82 in Crohn's disease. H Peeters S Bogaert D Laukens P Rottiers F De Keyser A Darfeuille-Michaud AL Glasser D Elewaut M De Vos, Int J Immunogenet 2007 34 181 191 10.1111/j.1744-313X.2007. 00670.x 17504508